Roosevelt Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.09M | Buy |
15,376
+2,380
| +18% | +$173K | 0.08% | 116 |
|
|
2022
Q2 | $1M | Buy |
12,996
+2
| +0% | +$152 | 0.07% | 127 |
|
|
2022
Q1 | $949K | Sell |
12,994
-100
| -0.8% | -$6.71K | 0.06% | 137 |
|
|
2021
Q4 | $816K | Buy |
13,094
+7,042
| +116% | +$413K | 0.05% | 150 |
|
|
2021
Q3 | $358K | Buy |
6,052
+100
| +2% | +$6.59K | 0.02% | 203 |
|
|
2021
Q2 | $398K | Sell |
5,952
-30
| -0.5% | -$1.96K | 0.02% | 195 |
|
|
2021
Q1 | $378K | Sell |
5,982
-1,753
| -23% | -$109K | 0.02% | 195 |
|
|
2020
Q4 | $480K | Sell |
7,735
-9,283
| -55% | -$571K | 0.03% | 167 |
|
|
2020
Q3 | $1.03M | Sell |
17,018
-8,317
| -33% | -$501K | 0.08% | 105 |
|
|
2020
Q2 | $1.49M | Sell |
25,335
-2,244
| -8% | -$134K | 0.15% | 67 |
|
|
2020
Q1 | $1.54M | Sell |
27,579
-789
| -3% | -$48.2K | 0.18% | 57 |
|
|
2019
Q4 | $1.82M | Buy |
28,368
+2,543
| +10% | +$146K | 0.19% | 53 |
|
|
2019
Q3 | $1.31M | Buy |
25,825
+4,316
| +20% | +$203K | 0.15% | 54 |
|
|
2019
Q2 | $975K | Sell |
21,509
-434
| -2% | -$20.2K | 0.11% | 64 |
|
|
2019
Q1 | $1.05M | Hold |
21,943
| – | – | 0.13% | 64 |
|
|
2018
Q4 | $1.14M | Buy |
+21,943
| New | +$1.18M | 0.12% | 87 |
|
|
2018
Q1 | – | Sell |
-3,642
| Closed | -$223K | – | 168 |
|
|
2017
Q4 | $223K | Buy |
3,642
+273
| +8% | +$17.1K | 0.02% | 170 |
|
|
2017
Q3 | $215K | Buy |
+3,369
| New | +$197K | 0.02% | 179 |
|
|
2017
Q2 | – | Sell |
-73,143
| Closed | -$3.98M | – | 189 |
|
|
2017
Q1 | $3.98M | Sell |
73,143
-86,681
| -54% | -$4.75M | 0.36% | 85 |
|
|
2016
Q4 | $9.34M | Sell |
159,824
-30,723
| -16% | -$1.68M | 0.83% | 50 |
|
|
2016
Q3 | $10.3M | Sell |
190,547
-40,735
| -18% | -$2.62M | 0.81% | 51 |
|
|
2016
Q2 | $17M | Sell |
231,282
-69,160
| -23% | -$4.89M | 1.32% | 29 |
|
|
2016
Q1 | $19.2M | Sell |
300,442
-122,931
| -29% | -$7.75M | 1.71% | 18 |
|
|
2015
Q4 | $29.1M | Buy |
423,373
+186,514
| +79% | +$12.3M | 1.91% | 15 |
|
|
2015
Q3 | $14M | Buy |
236,859
+227,617
| +2,463% | +$14.4M | 0.91% | 40 |
|
|
2015
Q2 | $615K | Sell |
9,242
-433
| -4% | -$28.5K | 0.04% | 175 |
|
|
2015
Q1 | $624K | Sell |
9,675
-60,508
| -86% | -$3.79M | 0.03% | 168 |
|
|
2014
Q4 | $4.14M | Buy |
70,183
+936
| +1% | +$52.8K | 0.23% | 70 |
|
|
2014
Q3 | $3.54M | Sell |
69,247
-285
| -0.4% | -$14.2K | 0.19% | 70 |
|
|
2014
Q2 | $3.37M | Sell |
69,532
-72,785
| -51% | -$3.59M | 0.14% | 67 |
|
|
2014
Q1 | $7.39M | Sell |
142,317
-40,590
| -22% | -$2.16M | 0.34% | 50 |
|
|
2013
Q4 | $9.72M | Buy |
182,907
+2,139
| +1% | +$109K | 0.44% | 45 |
|
|
2013
Q3 | $8.37M | Sell |
180,768
-39,320
| -18% | -$1.73M | 0.37% | 52 |
|
|
2013
Q2 | $9.84M | Buy |
+220,088
| New | +$9.56M | 0.44% | 49 |
|
Other funds holding BMY
Roosevelt Investment Group's BMY Position: Q3 2022 in Review
Roosevelt Investment Group increased its Bristol-Myers Squibb (BMY) stake by 18% in Q3 2022, buying an estimated $173K and bringing the position to 15,376 shares worth $1.09M. The position accounts for 0.08% of the portfolio, ranked #116.
Roosevelt Investment Group first reported a position in BMY in Q2 2013 and has held it in 34 quarters since. The position peaked at $29.1M in Q4 2015. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Roosevelt Investment Group held 15,376 shares of Bristol-Myers Squibb worth $1.09M as of Q3 2022.
- Roosevelt Investment Group bought 2,380 Bristol-Myers Squibb shares in Q3 2022, an estimated $173K.
- Bristol-Myers Squibb made up 0.08% of Roosevelt Investment Group's portfolio in Q3 2022, its #116 holding.
- Roosevelt Investment Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 34 quarters since.
- Roosevelt Investment Group's Bristol-Myers Squibb position peaked at $29.1M in Q4 2015.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.